ketoconazole and hydrazine

ketoconazole has been researched along with hydrazine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Clark, JE; Harder, DR; Kauser, K; Ma, YH; Masters, BS; Ortiz de Montellano, PR; Roman, RJ1
Badr, KF; Harris, RC; Munger, KA; Takahashi, K1
Li, F; Lu, J; Ma, X; Wang, L1
Arthanari, H; Bhyravabhotla, J; Boeszoermenyi, A; Buhrlage, SJ; Gelev, V; Gray, NS; Ji, F; Mukherjee, G; Näär, AM; Nishikawa, JL; Posteraro, B; Sadreyev, RI; Sanglard, D; Sanguinetti, M; Sohn, YJ; Torelli, R; Vale-Silva, LA; Wagner, G1

Other Studies

7 other study(ies) available for ketoconazole and hydrazine

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries.
    Circulation research, 1991, Volume: 68, Issue:4

    Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dogs; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Hydrazines; Indomethacin; Ketoconazole; Kinetics; Muscle, Smooth, Vascular; Phospholipases A; Phospholipases A2; Phosphorylcholine; Proadifen; Renal Artery; Triazoles

1991
Mediation of renal vascular effects of epidermal growth factor by arachidonate metabolites.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1990, Apr-01, Volume: 4, Issue:6

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Dinoprost; Epidermal Growth Factor; Fatty Acids, Unsaturated; Glomerular Filtration Rate; Hydrazines; Ibuprofen; Ketoconazole; Kidney; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Regional Blood Flow

1990
CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Aldehydes; Animals; Atazanavir Sulfate; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Feces; HIV Protease Inhibitors; Humans; Hydrazines; Ketoconazole; Metabolomics; Mice; Microsomes, Liver; Oligopeptides; Pyridines; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2011
Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
    Nature, 2016, Feb-25, Volume: 530, Issue:7591

    Topics: Animals; Antifungal Agents; Binding Sites; Candida glabrata; Candidiasis; DNA-Binding Proteins; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Hydrazines; Ketoconazole; Mediator Complex; Mice; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protein Structure, Tertiary; Saccharomyces cerevisiae Proteins; Thiourea; Trans-Activators; Transcription Factors; Transcriptional Activation; Up-Regulation

2016